Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Gulfcoast Clinical Research Center
932
mi
from 43215
Fort Myers, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Gulfcoast Clinical Research Center
932
mi
from 43215
Fort Myers, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Innova Clinical Trials
995
mi
from 43215
Miami, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Innova Clinical Trials
995
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Combined Research Orlando Phase I-IV LLC
795
mi
from 43215
Orlando, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Combined Research Orlando Phase I-IV LLC
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Olympian Clinical Research
831
mi
from 43215
Tampa, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Olympian Clinical Research
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
The University of South Florida Board of Trustees, A public Body Corporate, for University of South Florida
823
mi
from 43215
Tampa, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
The University of South Florida Board of Trustees, A public Body Corporate, for University of South Florida
823
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Northwest Behavioral Research Center
423
mi
from 43215
Marietta, GA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Northwest Behavioral Research Center
423
mi
from 43215
Marietta, GA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
AMR Baber Research Inc.
296
mi
from 43215
Naperville, IL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
AMR Baber Research Inc.
296
mi
from 43215
Naperville, IL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric Associates
623
mi
from 43215
Overland Park, KA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric Associates
623
mi
from 43215
Overland Park, KA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Louisiana Clinical Research
790
mi
from 43215
Shreveport, LA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Louisiana Clinical Research
790
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Sheppard Pratt Health System
343
mi
from 43215
Baltimore, MD
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sheppard Pratt Health System
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Univ of Massachusetts Med School
604
mi
from 43215
Worcester, MA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Univ of Massachusetts Med School
604
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric Care and Research Center
mi
from 43215
O'Fallon, MO
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric Care and Research Center
mi
from 43215
O'Fallon, MO
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
St. Charles Psychiatric Associates - Midwest Research Group
407
mi
from 43215
Saint Charles, MO
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
St. Charles Psychiatric Associates - Midwest Research Group
407
mi
from 43215
Saint Charles, MO
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Alivation Research
716
mi
from 43215
Lincoln, NE
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Alivation Research
716
mi
from 43215
Lincoln, NE
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Healthy Perspectives - Innovative Mental Health Services
629
mi
from 43215
Nashua, NH
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Healthy Perspectives - Innovative Mental Health Services
629
mi
from 43215
Nashua, NH
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
429
mi
from 43215
Berlin, NJ
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
429
mi
from 43215
Berlin, NJ
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Global Medical Institute, LLC
442
mi
from 43215
Princeton, NJ
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Global Medical Institute, LLC
442
mi
from 43215
Princeton, NJ
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Bio Behavioral Health
467
mi
from 43215
Toms River, NJ
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Bio Behavioral Health
467
mi
from 43215
Toms River, NJ
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Albuquerque Neuroscience Inc.
1327
mi
from 43215
Albuquerque, NM
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Albuquerque Neuroscience Inc.
1327
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
SPRI Clinical Trials LLC
480
mi
from 43215
Brooklyn, NY
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
SPRI Clinical Trials LLC
480
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Manhattan Behavioral Medicine, LLC
479
mi
from 43215
New York, NY
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Manhattan Behavioral Medicine, LLC
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Fieve Clinical Research
477
mi
from 43215
New York, NY
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Fieve Clinical Research
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
New Hope Clinical Research
349
mi
from 43215
Charlotte, NC
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
New Hope Clinical Research
349
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Dr. Cherian Verghese
403
mi
from 43215
Norristown, PA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Dr. Cherian Verghese
403
mi
from 43215
Norristown, PA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Research Strategies of Memphis, LLC
508
mi
from 43215
Memphis, TN
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Research Strategies of Memphis, LLC
508
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
North Texas Clinical Trials
938
mi
from 43215
Fort Worth, TX
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
North Texas Clinical Trials
938
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Grayline Clinical Drug Trials
951
mi
from 43215
Wichita Falls, TX
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Grayline Clinical Drug Trials
951
mi
from 43215
Wichita Falls, TX
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric And Behavioral Solutions
1513
mi
from 43215
Salt Lake City, UT
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric And Behavioral Solutions
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia
277
mi
from 43215
Charlottesville, VA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia
277
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric Alliance of The Blue Ridge
275
mi
from 43215
Charlottesville, VA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric Alliance of The Blue Ridge
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Houston Clinical Trials, LLC
993
mi
from 43215
Bellaire, TX
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Houston Clinical Trials, LLC
993
mi
from 43215
Bellaire, TX
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Research Centers of America
975
mi
from 43215
Hollywood, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Research Centers of America
975
mi
from 43215
Hollywood, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
623
mi
from 43215
Little Rock, AR
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
623
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
2021
mi
from 43215
Ventura, CA
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
2021
mi
from 43215
Ventura, CA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
716
mi
from 43215
Gainesville, FL
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
716
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
995
mi
from 43215
Miami, FL
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
995
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
979
mi
from 43215
Miramar, FL
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
979
mi
from 43215
Miramar, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
436
mi
from 43215
Atlanta, GA
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
785
mi
from 43215
Wichita, KA
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
785
mi
from 43215
Wichita, KA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
344
mi
from 43215
Baltimore, MD
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
643
mi
from 43215
Boston, MA
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
660
mi
from 43215
Flowood, MS
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
660
mi
from 43215
Flowood, MS
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
429
mi
from 43215
Marlton, NJ
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
429
mi
from 43215
Marlton, NJ
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
442
mi
from 43215
Princeton, NJ
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
442
mi
from 43215
Princeton, NJ
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
278
mi
from 43215
Chapel Hill, NC
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
278
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
348
mi
from 43215
Charlotte, NC
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
348
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Study Site
375
mi
from 43215
Raleigh, NC
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Study Site
375
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
1
mi
from 43215
Columbus, OH
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
1
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
416
mi
from 43215
Philadelphia, PA
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
525
mi
from 43215
Charleston, SC
A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
525
mi
from 43215
Charleston, SC
Click here to add this to my saved trials